and loss of germinal centers (Supplementary Fig. 1c) . The lungs and livers of Tet2-Tet3 DKO mice showed pronounced lymphocyte infiltration ( Supplementary Fig. 1c ). By 5-7 weeks, spleen cellularity was substantially increased (Fig. 1a) , and all of the mice succumbed by 8 weeks of age (Fig. 1b) . Disease development was associated with a massive expansion of iNKT cells in spleen and lymph nodes, even in young mice that maintained a normal reservoir of T reg cells (Fig. 1c,d) ; single deletion of Tet2 or Tet3 had a small, but significant, effect (Fig. 1e,f and Supplementary Fig. 1d,e) . Moreover, compared with their wild-type counterparts, 3-4-week-old Tet2-Tet3 DKO mice showed decreased thymic cellularity and decreased percentages and numbers of DP thymocytes, suggestive of intrathymic stress, as well as a relative increase in the number and frequency of CD4SP and CD8SP cells in the thymus (Supplementary Fig. 2a-d) . In contrast, peripheral lymphoid organs (spleen and lymph nodes) showed greatly increased cellularity despite decreased frequencies of peripheral CD4 + and CD8 + T cells ( Supplementary Fig. 2e-h) . Overall, simultaneous loss of Tet2 and Tet3 resulted in iNKT cell expansion and lethal disease.
Regulation of iNKT-cell-lineage specification by TET2 and TET3
Notably, the selective expansion of Tet2-Tet3 DKO iNKT cells was already apparent in the thymus of very young (20-day-old) Tet2-Tet3 DKO mice ( Fig. 2a-c) . The percentages and absolute numbers of thymic iNKT cells were much greater in Tet2-Tet3 DKO mice than in wild-type, Tet2 −/− or Tet3 KO mice ( Supplementary  Fig. 3a,b) . Compared with iNKT cells of the other genotypes, Tet2-Tet3 DKO iNKT cells showed increased expression of RORγt in the thymus and periphery and loss of CD4 expression, which suggested skewing toward an NKT17-like phenotype 6 ; decreased expression of Tbet in the thymus, which reflected a decrease in the number of NKT1-lineage cells; and increased expression of PLZF, consistent with a reduction in the number of cells of the NKT1 cell (PLZF lo ) lineage (Fig. 2d,e and Supplementary Fig. 3 ). In wild-type mice, more than 60% of iNKT cells were NKT1 cells, whereas the predominant NKT cell subtype in Tet2-Tet3 DKO mice was NKT17 ( Fig. 2f) . However, because of the prominent iNKT cell expansion in the thymus, all effector iNKT cell subtypes were overrepresented in thymocytes of Tet2-Tet3 DKO relative to their abundance in wild-type mice (Fig. 2g) . Consistent with their skewing toward the NKT17 cell lineage, Tet2-Tet3 DKO iNKT cells potently produced IL-17 when stimulated with phorbol 12-myristate 13-acetate (PMA) and ionomycin ( Supplementary Fig. 4a-c) . The frequency of IFN-γ-producing iNKT cells was diminished relative to wild type, but, as a result of the iNKT cell expansion, the percentage of IFN-γ-producing iNKT cells among total thymocytes was increased ( Supplementary Fig. 4d-f ). This was also observed for IL-4 ( Supplementary Fig. 4g-i) . Relative to wild type, the increased numbers of PLZF hi , IL-4 producing iNKT cells in Tet2-Tet3 DKO mice were associated with the expected increase in numbers of innate-like memory CD8SP cells 17 (Supplementary Fig. 4j,k) , which showed high expression of genes associated with an activated, memory-like phenotype (data not shown). Tet2-Tet3 DKO CD8 + cells were underrepresented in the periphery (Supplementary Fig. 2e-h ), presumably as a result of defects in migration and/or survival. We focused on the aberrant iNKT cells in Tet2-Tet3 DKO mice.
Tetramer hi NK1.1 − cells, which normally include CD4 + CD27 + NKT2 cells 6 , NKT17 cells that do not express CD4 (ref. 6 ) and NKT1 precursor cells identified by T-bet expression 18 , were greater in terms of both percentage and absolute numbers in Tet2-Tet3 DKO mice than in wild-type mice (Fig. 2h-j) . CD4 expression was almost undetectable in Tet2-Tet3 DKO iNKT cells, in contrast to its detectable expression in wild-type iNKT cells (Fig. 2h and Supplementary Fig. 3c ).
There was also a much larger PLZF + RORγt + population in the NK1.1 − Tet2-Tet3 DKO subset than in its wild-type counterpart ( Supplementary  Fig. 5a,b) , with a concomitant decrease in the PLZF + T-bet + subset that is thought to contain precursors of NKT1-cell-lineage cells ( Supplementary  Fig. 5c,d ). Compared with their wild-type counterparts, a small population of Tet2-Tet3 DKO tetramer + NK1.1 + CCR6 − CD27 + NKT1 cells exhibited higher expression of PLZF than that of their their wild-type counterparts and aberrant expression of RORγt, and a small fraction of this PLZF hi population did not express T-bet (Supplementary Fig.  5e ). The NK1.1 + Tet2-Tet3 DKO iNKT cells were not only less frequent among the thymic iNKT cells than their wild-type counterparts, but they were also functionally compromised, as they produced less IFN-γ than did wild-type cells (Supplementary Fig. 5f,g ). We concluded that Tet2 and Tet3 regulated the generation and maturation of these iNKT cell lineages.
NKT17 lineage skewing in Tet2-Tet3 DKO iNKT cells Transcriptional profiling of total thymic iNKT cells confirmed skewing toward the NKT17 cell lineage, with iNKT cells from young (3-to 4-week-old) Tet2-Tet3 DKO mice showing higher expression of Il17f, Rorc (which encodes RORγt) and Eomes and lower expression of Ifng, Il4, Tbx21 (which encodes T-bet) and Zbtb7b (which encodes ThPOK) than wild-type iNKT cells (Fig. 3a,b) . We also observed higher expression of Lef1, which can promote malignant transformation 19 ; Rag1, whose expression in NK cells correlates with an enhanced fitness, proliferative and survival capacity 20 ; and the oncogenes Lmo4 (ref. 21) and Myb 22 (Fig. 3a) . These genes iNKT cells (%)
iNKT subsets (%)
iNKT subsets (×10 normally have high expression in DP thymocytes and are progressively downregulated 1 , which indicates that Tet2-Tet3 deficiency results in developmental immaturity.
We also compared subtypes of wild-type and Tet2-Tet3 DKO iNKT cells (Fig. 3c) . Genes that were downregulated in Tet2-Tet3 DKO stage 0 iNKT precursors relative to their expression in wildtype cells included those encoding CD4, Bcl11b (which restricts the NKT17 lineage 23 ) and Satb1 (which forms complexes with PLZF in the presence of the Cullin E3 ligase 24 ); genes that were upregulated included Zbtb16 (which encodes PLZF) and Lmo4 (Fig. 3c) . In the heterogeneous NK1.1 − iNKT cell population, genes that were upregulated in Tet2-Tet3 DKO cells relative to their expression in wild-type cells included Rorc, Zbtb16 and Myc (whose product controls iNKT cell proliferation 25 ) , and genes that were downregulated included Cd4, Satb1, Tbx21 and Zbtb7b (Fig. 3c) . Combined loss of Tet2 and Tet3 affected the number, maturation and identity of the generated NKT1 cells; among the upregulated genes that we identified, Rorc and Lef1 (which is usually upregulated at an earlier stage (stage 0) of iNKT cell development) 18 were expressed in stage 1 and 2 iNKT cells but are normally absent in stage 3 iNKT cells 26 . Thus, TET2 and TET3 markedly affect the gene-expression profiles of all iNKT cell subsets.
Enhanced proliferation of Tet2-Tet3 DKO iNKT cells
The upregulation of Myc, Rag1, Lmo4, Myb and other genes associated with the iNKT precursor state and high proliferative capacity prompted us to assess the proliferation of Tet2-Tet3 DKO iNKT cells in vivo. We injected mice with BrdU, a thymidine analog that is incorporated into DNA during replication, and analyzed iNKT cells 16 h later. Indeed, Tet2-Tet3 DKO iNKT cells showed significantly higher BrdU incorporation than did wild-type thymic iNKT cells (Fig. 3d,e) .
Given that T reg cell function is compromised in Tet2-Tet3 DKO mice 27 , we sought to determine whether uncontrolled iNKT cell expansion would occur in the presence of intact T reg cells and, if so, whether antigen recognition would be involved. We transferred total Tet2-Tet3 DKO splenocytes (data not shown) or purified Tet2-Tet3 DKO iNKT cells (5 × 10 5 ) into fully immunocompetent (non-irradiated) CD45.1 + recipient mice, either wild-type or lacking CD1d. All wild-type recipients developed enlarged spleen and lymph nodes and succumbed to disease by 90 d, whereas all CD1d-deficient (CD1d KO) recipients remained healthy (Fig. 4a) . Spleen and lymph node cellularity increased significantly in the recipient mice, to an average of ~5 × 10 8 cells after transfer (Fig. 4b) ; of these, typically >80% were iNKT cells (Fig. 4c) . We also observed a slight expansion in CD1d KO recipients (Fig. 4b,c) .
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Compared with the expression of these genes in wild-type iNKT cells (Fig. 4d) 30 , whose products improve hematopoietic stem cell expansion and transplantation efficiency (Fig. 4d,e) . Pathway-enrichment analysis revealed two main categories of differentially expressed genes: those encoding products related to T cell function and those encoding products related to DNA replication, cell cycle and DNA damage repair (Fig. 4f) . Together these data indicated that loss of function of TET proteins conferred a cell-intrinsic phenotype of uncontrolled iNKT cell proliferation that was driven by antigen recognition and could be observed in recipient mice with normal immunological and T reg cell function.
TET2 and TET3 regulate chromatin accessibility 5hmC mapping by immunoprecipitation of DNA fragments containing cytosine-5-methylenesulfonate, the product of the reaction of 5hmC with sodium bisulfite (CMS-IP) 31, 32 . revealed that the greatest amounts of 5hmC in wild-type iNKT cells were present in the gene bodies of the genes with the highest expression (Fig. 5a,b) , as has been shown for other T cell types 13 . Whole-genome bisulfite sequencing (WGBS) of wild-type iNKT cells confirmed the expected inverse correlation between gene expression and DNA modification (5mC+5hmC) at promoters and transcription start sites (TSS) 33 and revealed that loss of 5mC+5hmC extended deeply into the gene bodies of the genes with the greatest transcription (Fig. 5c) . Relative to the abundance of 5mC and/or 5hmC at enhancers identified in embryonic stem cells or in cardiac tissue, thymus-specific enhancers 34 showed greater enrichment for 5hmC 13 (472 of 5,605 thymic enhancers intersect with 5hmC; Fig. 5d ). Their and their Average log 2 A r t i c l e s 5mC+5hmC content was greater in Tet2-Tet3 DKO iNKT cells than in wild-type iNKT cells (Fig. 5e) . Our data indicated that TET proteins were needed continuously to constrain CpG methylation of these enhancers in iNKT cells.
Comparing wild-type and young Tet2-Tet3 DKO iNKT cells, we found a much greater average abundance of 5mC+5hmC at the TSS and in gene bodies of Tet2-Tet3 DKO iNKT cells than in those of wild-type cells, whether we considered all genes (data not shown) or only differentially expressed genes (Supplementary Fig. 6a ). The increase was specific, as it was not seen in randomly chosen genome fragments of similar size (Supplementary Fig. 6a ). Both upregulated genes and downregulated genes in Tet2-Tet3 DKO iNKT cells showed similar increases 5mC+5hmC at promoters and TSSs, as well as gene-body modifications ( Supplementary  Fig. 6b ). Similar findings have been reported for Tet2-Tet3 DKO hematopoietic stem cells and precursor cells 35 . Overall, although it was clear that TET proteins regulated DNA modification in transcribed regions of the genome (promoters, gene bodies and enhancers), our data suggested a complex relationship between loss of TET protein function, the resulting increase in DNA methylation and changes in gene expression.
Nevertheless, our data suggested involvement of TET proteins in developmental transitions in lymphocytes. Comparing our WGBS data for wild-type iNKT cells with data for common lymphoid progenitor (CLP) cells 36 , we identified differentially methylated regions (DMRs) whose modification status changed during the differentiation of CLP cells into iNKT cells (Fig. 6a) . 2,100 regions gained 5mC+5hmC and 1,400 DMRs lost 5mC+5hmC. Focusing on differentiation-related DMRs that lost 5mC+5hmC during the CLP-to-iNKT cell transition, we found that Tet2-Tet3 DKO iNKT cells showed increased modification at these DMRs (Fig. 6a) , which indicated that loss of 5mC+5hmC during the CLP-to-iNKT cell transition required TET2 and TET3. Even in regions that gained modification as CLPs differentiated into iNKT cells, DNA modification increased further in Tet2-Tet3 DKO iNKT cells (Fig. 6a) , which suggested that cytosine methylation by DNA methyltransferases at these regions was unhindered in the absence of TET2 and TET3. All three TET proteins had higher expression in iNKT cells than in CLP cells 37 (Fig. 6b) .
We compared the genome-wide distribution of all DMRs with that of 5hmC. Two thirds of all DMRs, whether more highly modified in Tet2-Tet3 DKO iNKT cells or in wild-type iNKT cells, were located distal to promoter-TSS regions (that is, more than 5 kb from the TSS; Fig. 6c) . Of a total of 10,945 DMRs ( Table 1 ) that were more methylated (5mC+5hmC) in Tet2-Tet3 DKO iNKT cells than in wild-type cells, ~42% overlapped with regions that contained 5hmC in wild-type iNKT cells; of these, ~32% were near TSSs (±5 kb), corresponding to a total of 1,270 genes ( Table 1) . Only 183 (~14%) of these genes showed altered expression ( Table 1) . These results supported the idea that a subset of 5hmC-bearing promoters in wild-type cells acquire more 5mC+5hmC in the absence of TET function and that a small fraction of the corresponding genes show the expected correlation between increased promoter methylation and decreased expression. A caveat for this is that part, or all, of the modification that we measured might have been a result of 5hmC deposited by TET1.
Finally, we observed a strong correlation between 5hmC distribution and chromatin accessibility, as judged by assay of A r t i c l e s transposase-accessible chromatin sequencing (ATAC-seq) 38 (Fig. 7) . Although similar numbers of genomic regions gained and lost accessibility in Tet2-Tet3 DKO iNKT cells relative to their accessibility in wild-type cells (3,162 and 2,711, respectively), there was a marked overlap (37.5%) between differentially accessible regions (DARs) that lost accessibility in DKO iNKT cells and those that had 5hmC in wild-type iNKT cells (Fig. 7) . In contrast, only a few regions (2.7%) that gained accessibility in Tet2-Tet3 DKO iNKT cells relative to their accessibility in wild-type cells were marked by 5hmC in wild-type iNKT cells (Fig. 7a) . A considerably smaller fraction of DARs than of DMRs were located close to TSS (Fig. 7b) . Most DARs were located far from the TSS, whether they were less accessible in Tet2-Tet3 DKO iNKTs, more accessible in Tet2-Tet3 DKO iNKTs, or commonly accessible in both wild-type and Tet2-Tet3 DKO iNKTs. Overall, these data suggested a link between the loss of chromatin accessibility in Tet2-Tet3 DKO iNKT cells and the loss of 5hmC.
Regulation of iNKT-cell-lineage-specifying factors
Tet2-Tet3 deficiency affected the chromatin accessibility and DNAmodification status of several genes encoding products involved in iNKT cell lineage specification and function ( Supplementary Figs. 7  and 8 ). For example, a region near the TSS and first intron of Zbtb7b showed both a gain of 5mC+5hmC and a decrease in accessibility in Tet2-Tet3 DKO relative to such features in wild-type cells, Tet2-Tet3 DKO iNKT cells; note the large undermethylated canyon 39 in the Zbtb7b proximal promoter that gains 5mC+5hmC at its edges (Supplementary Fig. 7a ). Similarly, a region 5′ of the Tbx21 promoter that overlaps with a predicted thymic-specific enhancer 34 showed a perceptible gain of 5mC+5hmC and there was a concomitant decrease in Tbx21 mRNA expression in young Tet2-Tet3 DKO relative to its expression in wild-type iNKT cells ( Supplementary  Fig. 7b) . Moreover, an intragenic region in Tbx21 that overlaps a different predicted thymus-specific enhancer 34 showed lower accessibility in Tet2-Tet3 DKO iNKT cells than in wild-type iNKT cells (Supplementary Fig. 7b ). Other genes encoding cytokines and transcriptional regulators, such as Il4, Ifng, Bcl11b and Satb1, also showed downregulated expression, parallel loss of chromatin accessibility and gain of DNA modification, and this was sometimes, but not always, at the same genomic sites ( Supplementary Fig. 8 and data not shown). There were also examples in which a substantial increase in DNA modification was observed without a corresponding decrease in gene expression (for example, Gata3; data not shown). Overall, the data points to a stronger link between chromatin accessibility and 5hmC (measured by CMS-IP) than between chromatin accessibility and DNA modification (5mC+5hmC; measured by WGBS). Notably, of the 3,162 regions that showed greater chromatin accessibility in Tet2-Tet3 DKO iNKT cells than in wild-type cells, eight were located in the vicinity of Rorc (Supplementary Fig. 7c ), which correlated with higher expression of Rorc mRNA in Tet2-Tet3 DKO iNKT cells than in wild-type iNKT cells (Supplementary Fig. 7c) . One of these more-accessible regions, located upstream of the Rorc promoter, overlapped a predicted thymic-specific enhancer 34 ( Supplementary  Fig. 7c) . Furthermore, motif-enrichment analysis of the 3,162 DARs that were more accessible in Tet2-Tet3 DKO iNKT cells than in wildtype iNKT cells revealed considerable enrichment for the consensus RORγt-binding sequence (Fig. 7c) ; conversely, the 2,711 DARs that were less accessible in Tet2-Tet3 DKO iNKT cells than in wild-type iNKT cells showed enrichment for consensus binding sequences for T-box-and basic-region-leucine (bZIP) transcription factors (Fig. 7c) . Overall, the skewing toward the NKT17 cell lineage that we observed in Tet2-Tet3 DKO iNKT cells might be explained by a combination of greater chromatin accessibility at the Rorc promoter and gene body and the enrichment for RORγt-binding motifs and loss of T-bet-binding motifs in Tet2-Tet3 DKO iNKT cells relative to such features in wildtype iNKT cells.
Suppression of aberrant RORγt expression by ThPOK and T-bet
Unlike Tbx21 (which encodes T-bet) and Zbtb7b (which encodes ThPOK), which both had high expression in wild-type iNKT cells and contained large amounts of 5hmC (Fig. 5b) , Rorc had low expression and small amounts of 5hmC (Fig. 5b) . T-bet and ThPOK probably both repress RORγt expression: T-bet deficiency redirects the development of iNKT cells toward the NKT2 and NKT17 cell lineages 6, 40 , and decreased expression of ThPOK correlates with increased NKT17 differentiation 41 . To confirm that ThPOK and T-bet were able to suppress the aberrant overexpression of RORγt in Tet2-Tet3 DKO iNKT cells, we retrovirally expressed these transcription factors in Tet2-Tet3 DKO A r t i c l e s iNKT cells. Indeed, ThPOK, in the absence of TET2 and TET3, was sufficient to completely suppress RORγt expression (Fig. 8a,b) and IL-17 production (Fig. 8c) . T-bet, on the other hand, only partially suppressed RORγt expression in Tet2-Tet3 DKO iNKT cells (Fig. 8d,e) . We concluded that the decrease in ThPOK and T-bet expression in Tet2-Tet3 DKO iNKT cells might explain the increase in RORγt expression.
DISCUSSION
We studied mice with disrupted Tet2 and Tet3 genes at the DP stage of thymocyte development. Tet2-Tet3 DKO mice showed a marked disease phenotype that reflected multiple factors: compromised development, migration and function of several T cell subsets; uncontrolled expansion of NKT17-cell-lineage-skewed iNKT cells; the appearance of innate CD8 + cells that did not migrate to the periphery; and a dysfunctional phenotype of T reg cells, with unstable Foxp3 expression resulting from impaired demethylation of the intronic Foxp3 enhancer CNS2 (ref. 27 ). For all these disease features, loss of function of the TET proteins was necessary; individual deletion of TET2 or TET3 had only mild effects. The phenotype of iNKT cell expansion was already apparent in 3-week-old mice that had not yet developed the disease phenotype; it was recapitulated by the transfer of small numbers of highly purified Tet2-Tet3 DKO iNKT cells into immunocompetent recipient mice, which indicated that the expansion was not a result of the defect in functional T reg cells in Tet2-Tet3 DKO mice 27 . The expansion was antigen driven, as it was barely observed in CD1d-deficient recipient mice. T reg cells and iNKT cells were the two cell types most affected in Tet2-Tet3 DKO mice; a likely explanation is that conventional self-reactive T cells were deleted in the periphery, whereas both T reg cells and iNKT cells were 'agonist selected' and thus proliferated and survived 42 . The dominant iNKT cell phenotype might also reflect the highly proliferative nature of developing iNKT cells 3 . iNKT cell expansion is also common in mice lacking other epigenetic regulators, such as Ezh2 (ref. 43 ) and Jarid2 (ref. 44) , in T cells.
Notably, mice lacking individual TET proteins in T cells and hematopoietic stem cells show relatively mildly altered organismal phenotypes, such as individual germline deletions 45 . Deletions of Tet1 and Tet2 predispose mice to late-onset B cell malignancies and myeloid malignancies, respectively 45 . TET2 modulates cytokine production and gene expression in CD4 + helper T cells 46 and partially controls T reg cell function 27, 47 . However, inducible deletion of both Tet2 and Tet3 in mouse hematopoietic stem cells is needed to cause the rapid development of an aggressive acute myeloid leukemia 35 . One possible explanation for this is that TET1 and TET2 have distinct functions, whereas TET2 and TET3 have more redundant roles. Indeed, TET1 has a major role in the deposition of 5hmC at promoter and TSS regions in mouse embryonic stem cells, whereas TET2 (and, as shown here, TET3) seems to act predominantly at distal enhancers 48 . Because of the lack of commercially available chromatin-immunoprecipitation-quality antibodies, we were not able to pinpoint the genomic regions at which TET2 and TET3 act in T cells.
Our genome-wide analyses provided a detailed view of the relationships among DNA-modification status (5mC+5hmC, assessed by WGBS), 5hmC distribution (assessed by CMS-IP), chromatin accessibility (assessed by ATAC-seq) and gene expression in thymic iNKT cells. These factors are interconnected: several transcription factors and chromatin modifiers have been shown to recruit TET proteins 45 , and regions marked by 5hmC in wild-type iNKT cells showed more chromatin accessibility than that of Tet2-Tet3 DKO iNKT cells. DMRs that lost or gained DNA modification (5mC+5hmC) during CLP-toiNKT cell development also showed increased modification in Tet2-Tet3 DKO iNKT cells, which indicated that TET proteins participate in developmental transitions in lymphoid-lineage cells. Tbx21 and Zbtb7b, which encode the key transcriptional regulators T-bet and ThPOK, showed parallel decreases in 5hmC, chromatin accessibility and gene expression in Tet2-Tet3 DKO iNKT cells relative to such features in wild-type iNKT cells, which indicated a requirement for TET2 and TET3. In contrast, the marked increase in accessibility and expression of Rorc and RORγt inTet2-Tet3 DKO iNKT cells appeared to be mediated indirectly through decreased expression of T-bet and ThPOK, as overexpression of either T-bet or ThPOK in Tet2-Tet3 DKO iNKT cells suppressed RORγt expression. Future work will need to elucidate the precise sequence of molecular events that lead to TET-mediated control of iNKT cell expansion, lineage skewing and an acquisition of transmissible malignant phenotype.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 2) mice (B6(C)-Cd1d1tm1.2Aben/J) were purchased from Jackson laboratory. Both male and female mice were used in this study with similar findings. The majority of the experiments was done using young mice (3-5 weeks old as indicated). Analysis of older mice (6-8 weeks old) was performed to evaluate the lethal and aggressive nature of the observed phenotype.
ONLINE METHODS
For transfer experiments 5-6 weeks old recipients were used. The recipients were of the same sex as the donors. Both male and female recipients were used and similar results were obtained.
Histology. Organs were isolated from age-and sex-matched control and Tet2-Tet3 DKO mice and placed immediately in 10% formalin (Fisher), fixed overnight and then placed in 70% ethanol. Samples were paraffin-embedded, sectioned, stained with haematoxylin and eosin, and imaged using a Nikon Eclipse 80i microscope.
Flow Cytometry. Cells were isolated from thymus, spleen, lymph nodes and bone marrow. Surface staining was performed using antibodies from BioLegend: CD4 (RM4-5), CD8 (53-6. . PLZF (R17-809), T-bet (O4-46) and RORγt (Q31-378) were purchased from BD Pharmingen. In the initial stages of this study PLZF-Alexa Fluor 647 (D-9) was used and was obtained from Santa Cruz. α-GalCer-CD1d tetramer (conjugated either with PE or with BV421) was obtained from the NIH Tetramer Core. V α 14 iNKT cells were routinely defined as TCRβ intermediate, B220 − and positive for α-GalCer-CD1d tetramer binding. Intracellular staining for transcription factors PLZF, RORγt and Eomes was performed using the Foxp3 staining kit (cat no: 00-5523-00) from eBioscience. In order to evaluate the simultaneous expression of PLZF and T-bet in iNKT cell subsets a different staining strategy was followed that in our hands significantly increased the efficiency of T-bet staining 51 . Briefly, cells were surfaced stained, washed in flow cytometry staining buffer (PBS containing 3% FBS), resuspended in 100 µl PBS and then add 100 µl of 4% methanol-free formaldehyde (Pierce) to obtain a final concentration of 2% formaldehyde. Cells were fixed for 30 min, centrifuged and washed in 200 µl of 1× permeabilization buffer from the Foxp3 staining kit (cat no: 00-5523-00) from eBioscience. Subsequently, the cells were resuspended in 1x Permeabilization buffer (Foxp3 staining kit) containing PLZF-A647 (R17-809) and T-bet (O4-46) Alexa Fluor 488 and RORγt (Q31-378) PE CF594. Acquisition was performed in a BD LSR Fortessa (BD Biosciences) using the BD FACSDiva Software. Data analysis was performed with FlowJo (Treestar).
Ex vivo cytokine production. Thymocytes (in a concentration of 1 × 10 6 cells/ml) were stimulated in the presence of 50 ng/ml PMA and 1.5 µM ionomycin for 4 h. In the last 2 h of culture Brefeldin A was added in a concentration of 10 µg/ml. Cells were washed, stained for surface markers and fixed with 2% of formaldehyde for 15 min at 37 °C. Subsequently the protocol of the transcription factor staining set from BD was followed to stain for IL-4 (11B11), IL17-F (9D3.1C8) and IFN-γ (XMG1.2).
In vivo BrdU incorporation. Mice were intraperitoneally injected with 100 µl of 10 mg/ml BrdU. 16 h later mice were euthanized and the cells were stained for surface markers and subsequently for BrdU according to the accompanying protocol (BD Pharmingen, APC BrdU flow kit 552598). Technologies) . The unbound cells were incubated with 1 µg/ml Streptavidin A (Sigma-Aldrich) and subsequently stained with α-GalCer-loaded Cd1d tetramers and anti-TCRβ, after which tetramer-binding, TCRβ + cells were isolated using a FACSAria cell sorter (BD Biosciences). To obtain Tet2-Tet3 DKO cells, no depletion was performed since iNKT cells had proliferated extensively. Rather, live B220 − α-GalCer-Cd1d tetramer-binding, TCRβ + cells were isolated using a FACSAria cell sorter (BD Biosciences). Bulk RNA-seq. Total RNA was isolated from thymic iNKT cells isolated from young (3-4 weeks old) mice and spleens from wild type or congenic recipients of Tet2-Tet3 DKO iNKT cells using the E.Z.N.A. HP Total RNA kit (Omega) according to the manufacturer's instructions. Libraries were prepared using the Truseq RNA stranded kit (Illumina). The starting RNA material was 1 µg. Briefly, polyA + RNAs were selected with magnetic beads, the RNA was fragmented and cDNA was synthesized. After A-tailing and adaptor ligation, libraries were generated by amplifying the cDNA for 10-12 cycles. 3 different biological replicates per genotype were evaluated. The results of these experiments are shown in Figures 3a and 4d-f .
Transduction of Vα14
Micro-scaled RNA-seq (Smart-seq) of total iNKT cells. In this case, the starting total RNA for each library was 10 ng. RNA was isolated from wildtype, Tet3 KO and Tet2-Tet3 DKO iNKT cells (data depicted in Fig. 3b) we performed SMART-seq as previously described 53 . RNA was isolated using the RNeasy Micro kit (Qiagen). RNA was incubated with free dNTPs and tailed oligo-dT oligonucleotides. The reverse transcription reaction was performed at 42 °C in the presence of 1 M betaine (Sigma) and increased concentration of MgCl 2 (6 mM) to increase cDNA yield. SuperScript II reverse transcriptase and RNAse Out Inhibitor (Invitrogen) were used. Template switching oligonucleotides (TSO) were added to enable template switching by the reverse transcriptase, which synthesizes a complementary sequence to the TSO. Nine cycles of pre-amplification were performed using the KAPA HiFi HotStart Ready Mix (Kapa Biosystems). PCR products were purified with Ampure XP beads (Beckman Coulter) and quantified using High Sensitivity DNA Qubit (Life Technologies). The size distribution of the amplified DNA was evaluated
